Switch to:
Also traded in: Germany

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 6/10

vs
industry
vs
history
Cash to Debt 0.21
OMCL's Cash to Debt is ranked lower than
88% of the 1906 Companies
in the Global Health Information Services industry.

( Industry Median: 6.17 vs. OMCL: 0.21 )
Ranked among companies with meaningful Cash to Debt only.
OMCL' s Cash to Debt Range Over the Past 10 Years
Min: 0.18  Med: No Debt Max: No Debt
Current: 0.21
Equity to Asset 0.46
OMCL's Equity to Asset is ranked lower than
70% of the 1812 Companies
in the Global Health Information Services industry.

( Industry Median: 0.61 vs. OMCL: 0.46 )
Ranked among companies with meaningful Equity to Asset only.
OMCL' s Equity to Asset Range Over the Past 10 Years
Min: -0.57  Med: 0.7 Max: 0.78
Current: 0.46
-0.57
0.78
Interest Coverage 6.85
OMCL's Interest Coverage is ranked lower than
84% of the 1452 Companies
in the Global Health Information Services industry.

( Industry Median: 195.28 vs. OMCL: 6.85 )
Ranked among companies with meaningful Interest Coverage only.
OMCL' s Interest Coverage Range Over the Past 10 Years
Min: 6.85  Med: 410.61 Max: 2381.5
Current: 6.85
6.85
2381.5
F-Score: 4
Z-Score: 2.52
M-Score: -2.47
WACC vs ROIC
8.74%
3.02%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 8/10

vs
industry
vs
history
Operating margin (%) 2.86
OMCL's Operating margin (%) is ranked lower than
57% of the 1850 Companies
in the Global Health Information Services industry.

( Industry Median: 4.76 vs. OMCL: 2.86 )
Ranked among companies with meaningful Operating margin (%) only.
OMCL' s Operating margin (%) Range Over the Past 10 Years
Min: 0.31  Med: 7.72 Max: 11.25
Current: 2.86
0.31
11.25
Net-margin (%) 1.24
OMCL's Net-margin (%) is ranked lower than
59% of the 1850 Companies
in the Global Health Information Services industry.

( Industry Median: 3.09 vs. OMCL: 1.24 )
Ranked among companies with meaningful Net-margin (%) only.
OMCL' s Net-margin (%) Range Over the Past 10 Years
Min: 0.21  Med: 5.73 Max: 20.32
Current: 1.24
0.21
20.32
ROE (%) 1.98
OMCL's ROE (%) is ranked lower than
60% of the 1799 Companies
in the Global Health Information Services industry.

( Industry Median: 5.80 vs. OMCL: 1.98 )
Ranked among companies with meaningful ROE (%) only.
OMCL' s ROE (%) Range Over the Past 10 Years
Min: 0.19  Med: 6.39 Max: 25.13
Current: 1.98
0.19
25.13
ROA (%) 1.03
OMCL's ROA (%) is ranked lower than
58% of the 1912 Companies
in the Global Health Information Services industry.

( Industry Median: 2.83 vs. OMCL: 1.03 )
Ranked among companies with meaningful ROA (%) only.
OMCL' s ROA (%) Range Over the Past 10 Years
Min: 0.14  Med: 4.58 Max: 17.93
Current: 1.03
0.14
17.93
ROC (Joel Greenblatt) (%) 16.05
OMCL's ROC (Joel Greenblatt) (%) is ranked lower than
54% of the 1873 Companies
in the Global Health Information Services industry.

( Industry Median: 21.79 vs. OMCL: 16.05 )
Ranked among companies with meaningful ROC (Joel Greenblatt) (%) only.
OMCL' s ROC (Joel Greenblatt) (%) Range Over the Past 10 Years
Min: 2.43  Med: 49.63 Max: 91.06
Current: 16.05
2.43
91.06
Revenue Growth (3Y)(%) 12.90
OMCL's Revenue Growth (3Y)(%) is ranked higher than
72% of the 1428 Companies
in the Global Health Information Services industry.

( Industry Median: 5.10 vs. OMCL: 12.90 )
Ranked among companies with meaningful Revenue Growth (3Y)(%) only.
OMCL' s Revenue Growth (3Y)(%) Range Over the Past 10 Years
Min: -53.3  Med: 9.9 Max: 18.7
Current: 12.9
-53.3
18.7
EBITDA Growth (3Y)(%) 19.60
OMCL's EBITDA Growth (3Y)(%) is ranked higher than
70% of the 1186 Companies
in the Global Health Information Services industry.

( Industry Median: 7.90 vs. OMCL: 19.60 )
Ranked among companies with meaningful EBITDA Growth (3Y)(%) only.
OMCL' s EBITDA Growth (3Y)(%) Range Over the Past 10 Years
Min: -13.6  Med: 19.6 Max: 121.1
Current: 19.6
-13.6
121.1
EPS Growth (3Y)(%) 21.40
OMCL's EPS Growth (3Y)(%) is ranked higher than
70% of the 1076 Companies
in the Global Health Information Services industry.

( Industry Median: 7.60 vs. OMCL: 21.40 )
Ranked among companies with meaningful EPS Growth (3Y)(%) only.
OMCL' s EPS Growth (3Y)(%) Range Over the Past 10 Years
Min: -69.7  Med: 14.45 Max: 260.9
Current: 21.4
-69.7
260.9
GuruFocus has detected 1 Warning Sign with Omnicell Inc $OMCL.
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.
» OMCL's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow
Oprt. Cash Flow & Net Income

» Details

Guru Trades

Q1 2016

OMCL Guru Trades in Q1 2016

Paul Tudor Jones 17,445 sh (+76.21%)
Jim Simons Sold Out
Ken Fisher 531,000 sh (-4.15%)
» More
Q2 2016

OMCL Guru Trades in Q2 2016

Ken Fisher 536,152 sh (+0.97%)
Paul Tudor Jones Sold Out
» More
Q3 2016

OMCL Guru Trades in Q3 2016

Ken Fisher 517,464 sh (-3.49%)
» More
Q4 2016

OMCL Guru Trades in Q4 2016

Ken Fisher 507,114 sh (-2.00%)
» More
» Details

Insider Trades

Latest Guru Trades with OMCL

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Application Software » Health Information Services    NAICS: 621999    SIC: 8099
Compare:NAS:NH, NYSE:EVH, NAS:QSII, NYSE:TDOC, NAS:PINC, NAS:HSTM, NAS:INOV, NAS:WBMD, OTCPK:PMCUF, NYSE:EVDY, NAS:CPSI, OTCPK:ACHI, NAS:TRHC, OTCPK:COGZF, OTCPK:CNAB, OTCPK:TLLT, OTCPK:SMDCF, OTCPK:SNBP, OTCPK:OMCM, OTCPK:APTOF » details
Traded in other countries:OC9.Germany,
Omnicell Inc provides automation & business information solutions to update medication administration process & manage costly medical supplies for operational efficiency & patient safety. Its operating business segments are acute care & non-acute care.

Omnicell Inc is a Delaware corporation incorporated in California in 1992 under the name Omnicell Technologies, Inc. and reincorporated in Delaware in 2001 as Omnicell, Inc. The Company is a provider of automation and business information solutions enabling healthcare systems to streamline the medication administration process and manage costly medical supplies for increased operational efficiency and enhanced patient safety. The Company's automation, analytics and medication adherence solutions in hospitals and longer-term care environments are designed to enable healthcare facilities to acquire, manage, dispense and administer medications and medical-surgical supplies and are intended to enhance patient safety, reduce medication errors, reduce operating costs, improve workflow, and increase operational efficiency. Approximately 6,500 hospitals, institutional pharmacies, and retail pharmacies use Company's products. The Company is organized into two operating business segments: Acute Care, which includes products and services sold to hospital customers, and Non-Acute Care, which includes products and services sold to customers outside of the hospital setting. In acute care facilities, its solutions use software‑based medication control and tracking algorithms that interact with hardware security features, resulting in a system that provides both the pharmacist and the nurse real-time safety controls. It also provides medication bar code verification at every step of the medication administration process, from entry to the hospital through the administration of the medication to a patient. Its systems enables customers to reduce or eliminate inefficiencies such as manual tracking and reconciliations, nursing time spent in obtaining medications and in performing inventory control and extraneous process steps. Similar to its medication solutions, Company's medical and surgical supply systems provide hospitals control over consumable supplies critical to providing quality healthcare. Its solutions provide inventory control software that is designed to ensure critical supplies are always stocked in the right locations. It also offers analytics and reporting software for pharmacists and material managers to more easily manage inventory flow, tracking and optimization. The Non-Acute Care segment represents products sold outside the hospital setting and includes medication adherence products sold under the brand name of MTS, and dispensing systems sold under the Omnicell brand. The MTS products consist of proprietary medication packaging systems and related products for use by institutional pharmacies servicing long-term care, and correctional facilities or retail pharmacies serving patients in their local communities. These systems use consumable medication punch cards and specialized machines that allow the pharmacies to automatically or semi-automatically assemble, fill and seal drugs into medication punch cards representing a week

Ratios

vs
industry
vs
history
P/E(ttm) 147.96
OMCL's P/E(ttm) is ranked lower than
93% of the 1213 Companies
in the Global Health Information Services industry.

( Industry Median: 24.90 vs. OMCL: 147.96 )
Ranked among companies with meaningful P/E(ttm) only.
OMCL' s P/E(ttm) Range Over the Past 10 Years
Min: 8.9  Med: 42.29 Max: 1353
Current: 147.96
8.9
1353
Forward P/E 19.34
OMCL's Forward P/E is ranked higher than
54% of the 301 Companies
in the Global Health Information Services industry.

( Industry Median: 20.45 vs. OMCL: 19.34 )
Ranked among companies with meaningful Forward P/E only.
N/A
PE(NRI) 147.96
OMCL's PE(NRI) is ranked lower than
93% of the 1210 Companies
in the Global Health Information Services industry.

( Industry Median: 25.80 vs. OMCL: 147.96 )
Ranked among companies with meaningful PE(NRI) only.
OMCL' s PE(NRI) Range Over the Past 10 Years
Min: 8.9  Med: 42.29 Max: 1353
Current: 147.96
8.9
1353
Price/Owner Earnings (ttm) 56.61
OMCL's Price/Owner Earnings (ttm) is ranked lower than
80% of the 746 Companies
in the Global Health Information Services industry.

( Industry Median: 23.89 vs. OMCL: 56.61 )
Ranked among companies with meaningful Price/Owner Earnings (ttm) only.
OMCL' s Price/Owner Earnings (ttm) Range Over the Past 10 Years
Min: 7.72  Med: 33.22 Max: 3988.33
Current: 56.61
7.72
3988.33
P/B 2.77
OMCL's P/B is ranked higher than
50% of the 1779 Companies
in the Global Health Information Services industry.

( Industry Median: 2.86 vs. OMCL: 2.77 )
Ranked among companies with meaningful P/B only.
OMCL' s P/B Range Over the Past 10 Years
Min: 0.96  Med: 2.35 Max: 6.93
Current: 2.77
0.96
6.93
P/S 1.82
OMCL's P/S is ranked higher than
56% of the 1765 Companies
in the Global Health Information Services industry.

( Industry Median: 2.26 vs. OMCL: 1.82 )
Ranked among companies with meaningful P/S only.
OMCL' s P/S Range Over the Past 10 Years
Min: 0.95  Med: 2.17 Max: 4.68
Current: 1.82
0.95
4.68
PFCF 30.10
OMCL's PFCF is ranked lower than
63% of the 659 Companies
in the Global Health Information Services industry.

( Industry Median: 25.00 vs. OMCL: 30.10 )
Ranked among companies with meaningful PFCF only.
OMCL' s PFCF Range Over the Past 10 Years
Min: 7.86  Med: 31.12 Max: 2576
Current: 30.1
7.86
2576
POCF 22.66
OMCL's POCF is ranked lower than
65% of the 830 Companies
in the Global Health Information Services industry.

( Industry Median: 17.48 vs. OMCL: 22.66 )
Ranked among companies with meaningful POCF only.
OMCL' s POCF Range Over the Past 10 Years
Min: 6.85  Med: 20.61 Max: 841.67
Current: 22.66
6.85
841.67
EV-to-EBIT 75.60
OMCL's EV-to-EBIT is ranked lower than
88% of the 1184 Companies
in the Global Health Information Services industry.

( Industry Median: 17.51 vs. OMCL: 75.60 )
Ranked among companies with meaningful EV-to-EBIT only.
OMCL' s EV-to-EBIT Range Over the Past 10 Years
Min: 5.7  Med: 24.75 Max: 219.2
Current: 75.6
5.7
219.2
EV-to-EBITDA 20.21
OMCL's EV-to-EBITDA is ranked lower than
66% of the 1281 Companies
in the Global Health Information Services industry.

( Industry Median: 13.65 vs. OMCL: 20.21 )
Ranked among companies with meaningful EV-to-EBITDA only.
OMCL' s EV-to-EBITDA Range Over the Past 10 Years
Min: 4  Med: 15.3 Max: 46.1
Current: 20.21
4
46.1
PEG 4.75
OMCL's PEG is ranked lower than
77% of the 558 Companies
in the Global Health Information Services industry.

( Industry Median: 2.01 vs. OMCL: 4.75 )
Ranked among companies with meaningful PEG only.
OMCL' s PEG Range Over the Past 10 Years
Min: 0.4  Med: 1.7 Max: 79.04
Current: 4.75
0.4
79.04
Shiller P/E 59.72
OMCL's Shiller P/E is ranked lower than
69% of the 286 Companies
in the Global Health Information Services industry.

( Industry Median: 38.52 vs. OMCL: 59.72 )
Ranked among companies with meaningful Shiller P/E only.
OMCL' s Shiller P/E Range Over the Past 10 Years
Min: 36.8  Med: 55.26 Max: 75.09
Current: 59.72
36.8
75.09
Current Ratio 1.70
OMCL's Current Ratio is ranked lower than
59% of the 1854 Companies
in the Global Health Information Services industry.

( Industry Median: 2.01 vs. OMCL: 1.70 )
Ranked among companies with meaningful Current Ratio only.
OMCL' s Current Ratio Range Over the Past 10 Years
Min: 0.64  Med: 2.41 Max: 5.21
Current: 1.7
0.64
5.21
Quick Ratio 1.33
OMCL's Quick Ratio is ranked lower than
67% of the 1854 Companies
in the Global Health Information Services industry.

( Industry Median: 1.85 vs. OMCL: 1.33 )
Ranked among companies with meaningful Quick Ratio only.
OMCL' s Quick Ratio Range Over the Past 10 Years
Min: 0.4  Med: 2.09 Max: 4.95
Current: 1.33
0.4
4.95
Days Inventory 66.55
OMCL's Days Inventory is ranked lower than
79% of the 1072 Companies
in the Global Health Information Services industry.

( Industry Median: 17.60 vs. OMCL: 66.55 )
Ranked among companies with meaningful Days Inventory only.
OMCL' s Days Inventory Range Over the Past 10 Years
Min: 35.43  Med: 54.71 Max: 77.78
Current: 66.55
35.43
77.78
Days Sales Outstanding 99.26
OMCL's Days Sales Outstanding is ranked lower than
74% of the 1485 Companies
in the Global Health Information Services industry.

( Industry Median: 67.06 vs. OMCL: 99.26 )
Ranked among companies with meaningful Days Sales Outstanding only.
OMCL' s Days Sales Outstanding Range Over the Past 10 Years
Min: 56.2  Med: 69.17 Max: 99.26
Current: 99.26
56.2
99.26
Days Payable 38.68
OMCL's Days Payable is ranked lower than
54% of the 1313 Companies
in the Global Health Information Services industry.

( Industry Median: 42.66 vs. OMCL: 38.68 )
Ranked among companies with meaningful Days Payable only.
OMCL' s Days Payable Range Over the Past 10 Years
Min: 27.77  Med: 35.76 Max: 46.45
Current: 38.68
27.77
46.45

Buy Back

vs
industry
vs
history
3-Year Average Share Buyback Ratio -2.00
OMCL's 3-Year Average Share Buyback Ratio is ranked higher than
53% of the 1122 Companies
in the Global Health Information Services industry.

( Industry Median: -2.50 vs. OMCL: -2.00 )
Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.
OMCL' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -140.8  Med: -4 Max: 1.6
Current: -2
-140.8
1.6

Valuation & Return

vs
industry
vs
history
Price/Projected FCF 1.54
OMCL's Price/Projected FCF is ranked higher than
61% of the 817 Companies
in the Global Health Information Services industry.

( Industry Median: 1.93 vs. OMCL: 1.54 )
Ranked among companies with meaningful Price/Projected FCF only.
OMCL' s Price/Projected FCF Range Over the Past 10 Years
Min: 0.94  Med: 1.51 Max: 8.59
Current: 1.54
0.94
8.59
Price/DCF (Earnings Based) 13.85
OMCL's Price/DCF (Earnings Based) is ranked lower than
98% of the 121 Companies
in the Global Health Information Services industry.

( Industry Median: 1.55 vs. OMCL: 13.85 )
Ranked among companies with meaningful Price/DCF (Earnings Based) only.
N/A
Price/Median PS Value 0.84
OMCL's Price/Median PS Value is ranked higher than
75% of the 1497 Companies
in the Global Health Information Services industry.

( Industry Median: 1.11 vs. OMCL: 0.84 )
Ranked among companies with meaningful Price/Median PS Value only.
OMCL' s Price/Median PS Value Range Over the Past 10 Years
Min: 0.23  Med: 1.03 Max: 2.21
Current: 0.84
0.23
2.21
Price/Peter Lynch Fair Value 5.92
OMCL's Price/Peter Lynch Fair Value is ranked lower than
93% of the 312 Companies
in the Global Health Information Services industry.

( Industry Median: 1.72 vs. OMCL: 5.92 )
Ranked among companies with meaningful Price/Peter Lynch Fair Value only.
OMCL' s Price/Peter Lynch Fair Value Range Over the Past 10 Years
Min: 0.69  Med: 1.92 Max: 46.76
Current: 5.92
0.69
46.76
Earnings Yield (Greenblatt) (%) 1.34
OMCL's Earnings Yield (Greenblatt) (%) is ranked lower than
57% of the 1833 Companies
in the Global Health Information Services industry.

( Industry Median: 2.40 vs. OMCL: 1.34 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) (%) only.
OMCL' s Earnings Yield (Greenblatt) (%) Range Over the Past 10 Years
Min: 0.5  Med: 4.05 Max: 17.7
Current: 1.34
0.5
17.7
Forward Rate of Return (Yacktman) (%) 28.98
OMCL's Forward Rate of Return (Yacktman) (%) is ranked higher than
85% of the 751 Companies
in the Global Health Information Services industry.

( Industry Median: 10.28 vs. OMCL: 28.98 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) (%) only.
OMCL' s Forward Rate of Return (Yacktman) (%) Range Over the Past 10 Years
Min: -2.6  Med: 28.45 Max: 43.8
Current: 28.98
-2.6
43.8

More Statistics

Revenue (TTM) (Mil) $651.0
EPS (TTM) $ 0.22
Beta0.85
Short Percentage of Float5.55%
52-Week Range $25.06 - 40.50
Shares Outstanding (Mil)36.52

Analyst Estimate

Dec16 Dec17 Dec18
Revenue (Mil $) 703 762 847
EPS ($) 1.45 1.73 2.21
EPS w/o NRI ($) 1.45 1.73 2.21
EPS Growth Rate
(3Y to 5Y Estimate)
N/A
Dividends Per Share ($)

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)